David Mott

New Enterprise Associates General Partner

Photo of David Mott, General Partner at New Enterprise Associates
$200k - $40.0m
$10.0m
CompanyDeal TypeAmountDate
Nightstar TherapeuticsSeries C$45MJun 2017
ArdelyxPost-IPO Equity$110MJul 2016
Nightstar TherapeuticsSeries B$35M (Lead)Nov 2015
Clementia PharmaceuticalsVenture Round$60M (Lead)Jun 2015
ArdelyxPost-IPO Equity$77.8M (Lead)Jun 2015
AdaptimmuneSeries A$104M (Lead)Sep 2014
CydanVenture Round$10MOct 2013
Edimer PharmaceuticalsSeries B$18M (Lead)Jul 2013
CydanVenture Round$16M (Lead)Apr 2013
ProsensaVenture Round€23M (Lead)Jan 2012
No media found for David Mott.
cb
Photo of Aaron Jacobson, Partner at New Enterprise Associates

New Enterprise Associates

Photo of Albert Lee, New Enterprise Associates

New Enterprise Associates

AB

New Enterprise Associates

Photo of Amit Mukherjee, Partner at New Enterprise Associates

New Enterprise Associates

AS

New Enterprise Associates